Edgewise Therapeutics (EWTX) is up 23.3%, or $7.33 to $38.78.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
- JPMorgan ups Edgewise target, adds to Analyst Focus List
- Edgewise Therapeutics Completes Key Renal Study for EDG-7500, Setting Up Next Steps for Investors
- Edgewise Therapeutics’ sevasemten shows efficacy in Becker disorder
- Controversial Prasad leaving FDA, NYT reports